DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Secreted frizzled‐related protein 2 (sFRP2) is a negative modulator of the Wingless‐type (Wnt) signaling pathway, and shown to be inactivated in renal cell carcinoma (RCC). However, the molecular mechanism of silencing of sFRP2 is not fully understood. Our study was designed to elucidate the silencing mechanism of sFRP2 in RCC. Expression of sFRP2 was examined in 20 pairs of primary cancers by immunohistochemistry. Kidney cell lines (HK‐2, Caki‐1, Caki‐2, A‐498 and ACHN) were analyzed for sFRP2 expression using real‐time RT‐PCR and Western blotting. The methylation status at 46 CpG sites of the 2 CpG islands in the sFRP2 promoter was characterized by bisulfite DNA sequencing. Histone modifications were assessed by chromatin immunoprecipitation (ChIP) assay using antibodies against AcH3, AcH4, H3K4 and H3K9. sFRP2 was frequently repressed in primary cancers and in RCC cells. The majority of sFRP2 negative cells had a methylated promoter. Meanwhile, sFRP2 expression was repressed by a hypomethylated promoter in Caki‐1 cells, and these cells had a repressive histone modification at the promoter. In Caki‐1 cells, sFRP2 was reactivated by trichostatin A (TSA). Repressive histone modifications were also observed in RCC cells with hypermethylated promoters, but sFRP2 was reactivated only by 5‐aza‐2′‐deoxycytidine (DAC) and not by TSA. However, the activation of the silenced sFRP2 gene could be achieved in all cells using a combination of DAC and TSA. This is the first report indicating that aberrant DNA methylation and histone modifications work together to silence the sFRP2 gene in RCC cells. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway
McCabe, M. T., Davis, J. N., & Day, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2158 · Cited by 172
Cited by
Epigenetically Altered Wound Healing in Keloid Fibroblasts
Russell, S. B., Russell, J. D., Trupin, K. M., Gayden, A. E., Opalenik, S. R., Nanney, L. B., Broquist, A. H., Raju, L., & Williams, S. M. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.162 · Cited by 167
“Silencing of SFRP1 is not due to hypermethylation in keloid fibroblasts; increased SFRP1 expression in response to Trichostatin A is consistent with a role for decreased histone acetylation in keloid fibroblasts Epigenetic silencing of tumor promoters by hypermethylation and differential histone acetylation, including…”
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms
De Bruyne, E., Bos, T. J., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., Atadja, P., Jernberg-Wiklund, H., & Vanderkerken, K. (2010) · Blood · doi:10.1182/blood-2009-07-232801 · Cited by 103
Wnt Signaling in Renal Cell Carcinoma
Xu, Q., Krause, M., Samoylenko, A., & Vainio, S. (2016) · Cancers · doi:10.3390/cancers8060057 · Cited by 99
Metadata
- Authors
- Kawamoto, K., Hirata, H., Kikuno, N., Tanaka, Y., Nakagawa, M., & Dahiya, R.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-05-28
- Volume
- 123
- Issue
- 3
- Pages
- 535-542
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1973267581
- Cited by
- 56
- References
- 2
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.